AI를 활용한 혁신 신약개발의 동향 및 정책 시사점

Summary

The South Korean pharmaceutical and bio industry faces declining profitability due to widespread patent expirations, decreased clinical trial success rates, and rising development costs. To overcome these challenges, the document highlights innovative drug development utilizing AI as a key solution to enhance R&D productivity, with government initiatives like the 'AI Drug Development K-Melody Project' and 'National Integrated Bio Big Data Construction Project' already underway. While there's significant potential, the domestic industry's adoption of AI in drug development is still in its early stages, with limited concrete outcomes so far, largely due to fragmented efforts and regulatory hurdles.

Key Facts

Source Document

https://example-government.gov/policy-document-link